By Prof John Olynyk, Curtin University
Hepatic cirrhosis and hepatocellular carcinoma (HCC) are rapidly increasing causes of premature morbidity and death globally.
In 2021, Deloitte Access Economics reported costs of HCC to the health system, productivity and loss of wellbeing in Australia were $140m, $382m and $4.3b a year, respectively.
HCC is the second most common global cause of years-of-life-lost due to malignancy, and the commonest cause of death in cirrhosis....
Hepatic cirrhosis and hepatocellular carcinoma (HCC) are rapidly increasing causes of premature morbidity and death globally.
In 2021, Deloitte Access Economics reported costs of HCC to the health system, productivity and loss of wellbeing in Australia were $140m, $382m and $4.3b a year, respectively.
HCC is the second most common global cause of years-of-life-lost due to malignancy, and the commonest cause of death in cirrhosis....
This content is restricted to Medical Forum readers; this is a new feature. If you haven’t registered with our site in the last few weeks, please create a new account below. If you have subscribed, please log in.